Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Alzheimer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Not applicableUnknownNCT04550975
What this trial is testing

Advanced Cognitive Stimulation Therapy (ACST)

Who this might be right for
DEMDementiaDementia, Vascular+6 more
University College, London 32
Testing effectiveness (Phase 2)Study completedNCT01735630
What this trial is testing

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 350
Not applicableEnded earlyNCT01001637
What this trial is testing

Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Jaslok Hospital and Research Centre 26
Post-approval studies (Phase 4)UnknownNCT05430867
What this trial is testing

Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
TreatmentEfficacySafety+1 more
First Affiliated Hospital Xi'an Jiaotong University 150
Post-approval studies (Phase 4)UnknownNCT01849042
What this trial is testing

Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Konkuk University Medical Center 188
Post-approval studies (Phase 4)Study completedNCT07417670
What this trial is testing

Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Carnot Laboratories 105
Large-scale testing (Phase 3)Study completedNCT00090116
What this trial is testing

The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 400
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Post-approval studies (Phase 4)Study completedNCT02097056
What this trial is testing

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Korea Inc. 171
Large-scale testing (Phase 3)Not Yet RecruitingNCT05303701
What this trial is testing

GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)

Who this might be right for
Moderate to Severe Alzheimer's Disease
Samsung Pharmaceutical Co., Ltd. 750
Not applicableStudy completedNCT01796314
What this trial is testing

Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life

Who this might be right for
Alzheimer Disease
University Hospital, Toulouse 170
Not applicableUnknownNCT04555629
What this trial is testing

Advanced Cognitive Stimulation Therapy Hong Kong (ACST-HK)

Who this might be right for
DementiaDementia, VascularDementia, Mixed+5 more
University College, London 32
Not applicableStudy completedNCT01081743
What this trial is testing

Effectiveness of Care Management in Alzheimer Patients

Who this might be right for
Alzheimer Disease or Associated DisorderMild to Moderately Severe Dementia
Institut de Sante Publique, d'Epidemiologie et de Developpement 270
Testing effectiveness (Phase 2)Study completedNCT00325728
What this trial is testing

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Chronic Insomnia
Takeda 74
Not applicableStudy completedNCT03328195
What this trial is testing

Vielight Neuro RX Gamma - Feasibility Pilot

Who this might be right for
Alzheimer Disease
Vielight Inc. 60
Large-scale testing (Phase 3)Study completedNCT00566501
What this trial is testing

Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 915
Testing effectiveness (Phase 2)Study completedNCT03560245
What this trial is testing

Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine

Who this might be right for
Alzheimer Disease
Neurotrope Bioscience, Inc. 108
Large-scale testing (Phase 3)Ended earlyNCT00912288
What this trial is testing

Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 86